Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial
- PMID: 2494246
- DOI: 10.1016/0735-1097(89)90250-7
Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of phase I Thrombolysis in Myocardial Infarction (TIMI) trial
Abstract
In Thrombolysis in Myocardial Infarction (TIMI) Phase I,290 patients with acute myocardial infarction were randomized to either intravenous recombinant tissue-type plasminogen activator (rt-PA) or intravenous streptokinase. Two hundred twenty-nine patients had radionuclide ventriculograms at discharge for assessment of global and regional left ventricular ejection fraction. Among these 229 patients 185 had totally occluded infarct-related arteries, and angiographic reperfusion of the infarct-related artery occurred in 69% of patients treated with rt-PA and 28% of patients treated with streptokinase (p less than 0.001). Mean global left ventricular ejection fraction was not different for rt-PA-treated patients compared with streptokinase-treated patients (0.46 versus 0.45). However, the average regional ejection fraction of the regions subtended by the infarct-related artery showed a trend toward better average infarct region ejection fraction in patients treated with rt-PA than in patients treated with streptokinase (0.40 versus 0.36; 0.05 less than p less than 0.06). Analysis of data according to perfusion status of the infarct-related artery showed no difference in mean global left ventricular ejection fraction between patients with sustained versus nonsustained reperfusion (0.47 versus 0.44). However, there was better average regional ejection fraction of the region subtended by the infarct-related artery in patients with sustained reperfusion (0.40 versus 0.36; p less than 0.01). Thus, quantitation of regional left ventricular function by radionuclide techniques provides a noninvasive means for evaluating the effects of thrombolysis. This study suggests a direct relation between improvement of regional left ventricular function and the greater infarct-related artery patency rate achieved by rt-PA compared with streptokinase.
Similar articles
-
The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial.Circulation. 1987 Apr;75(4):817-29. doi: 10.1161/01.cir.75.4.817. Circulation. 1987. PMID: 3103950 Clinical Trial.
-
Heart rate variability assessment early after acute myocardial infarction. Pathophysiological and prognostic correlates. GUSTO ECG Substudy Investigators. Global Utilization of Streptokinase and TPA for Occluded Arteries.Circulation. 1996 Apr 1;93(7):1388-95. doi: 10.1161/01.cir.93.7.1388. Circulation. 1996. PMID: 8641028
-
Independent impact of thrombolytic therapy and vessel patency on left ventricular dilation after myocardial infarction. Serial echocardiographic follow-up.Circulation. 1994 Aug;90(2):800-7. doi: 10.1161/01.cir.90.2.800. Circulation. 1994. PMID: 8044951
-
New developments in thrombolytic therapy.Adv Exp Med Biol. 1990;281:333-54. Adv Exp Med Biol. 1990. PMID: 2129372 Review.
-
Reperfusion therapy in inferior myocardial infarction.J Am Coll Cardiol. 1988 Dec;12(6 Suppl A):44A-51A. doi: 10.1016/0735-1097(88)92640-x. J Am Coll Cardiol. 1988. PMID: 3142944 Review.
Cited by
-
Gated fluorine 18 fluorodeoxyglucose positron emission tomography: determination of global and regional left ventricular function and myocardial tissue characterization.J Nucl Cardiol. 2003 May-Jun;10(3):297-303. doi: 10.1016/s1071-3581(02)43240-0. J Nucl Cardiol. 2003. PMID: 12794629
-
Therapeutic options in treating acute myocardial infarction.West J Med. 1989 Oct;151(4):440-7. West J Med. 1989. PMID: 2531500 Free PMC article. Review.
-
Assessment of reperfusion after acute myocardial infarction: is there a role for acute technetium 99m-teboroxime imaging?J Nucl Cardiol. 1996 Jan-Feb;3(1):82-5. doi: 10.1016/s1071-3581(96)90027-6. J Nucl Cardiol. 1996. PMID: 8799231 No abstract available.
-
Assessing prognosis after acute myocardial infarction in the thrombolytic era.J Nucl Cardiol. 1994 Mar-Apr;1(2 Pt 1):198-209. doi: 10.1007/BF02984092. J Nucl Cardiol. 1994. PMID: 9420687 Review.
-
The role of coronary artery collaterals in the preservation of left ventricular function: a study to address a long-standing controversy.Cardiovasc J Afr. 2017 Mar/Apr;28(2):81-85. doi: 10.5830/CVJA-2016-054. Cardiovasc J Afr. 2017. PMID: 28470330 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical